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Pancreatic encephalopathy refers to a gamut of neuropsychiatric symptoms compli-
cating acute pancreatitis. Osmotic myelinolysis is a known complication of pancreatic
encephalopathy. We evaluated a 58-year-old woman with pancreatic encephalopathy asso-
ciated to pontine and extrapontine myelinolysis involving the brain and spinal cord. To our
knowledge, this is the first clinic pathological case report of pancreatic encephalopathy
involving the spinal cord.
Keywords: pancreatic encephalopathy, osmotic myelinolysis, extrapontine myelinolysis, pontine myelinolysis,
leukoencephalopathy
A 58-year-old right handed woman was brought to the emer-
gency room after being found on the floor by her daughter.
Fifteen days prior to admission she was admitted to an out-
side hospital for an ampulla of Vater adenoma resection and
pancreatic duct stenting. An endoscopic retrograde cholangio-
pancreatography (ERCP) was complicated by acute pancreati-
tis (serum lipase> 5000 units/L) due to stent migration. The
stent was removed 2 days following the procedure. No elec-
trolyte derangements were observed during her hospitalization.
She remained hospitalized for another week and was reported
to have “manipulative behavior.” It was also noted that 1 week
prior to admission to our hospital (1 week post-surgery), she was
diagnosed with depression and attention deficit disorder and was
started on methylphenidate and bupropion. Her family stated she
had become “less conversational, sleepy, and odd” and referred to
a psychiatrist.
Medical history was remarkable for a chronic postpran-
dial abdominal pain, hypertension, and a large calcified
pelvic mass assumed to be a leiomyoma. Outpatient med-
ications included lisinopril, tramadol, sustained release bupro-
pion, and methylphenidate. Upon admission to our hospi-
tal, she complained of persistent abdominal pain and somno-
lence.
On examination, there was an apical systolic murmur, diffuse
abdominal discomfort to palpation, normal bowel sounds, and no
peritoneal signs.
Initial blood work showed a hemoglobin of 13.1 g/dL,
white blood cell count (WBC) of 16.6 K/UL (lymphocytes 4%,
monocytes 10%, granulocytes 85%), platelets 324 K/UL. Basic
metabolic profile (BMP), liver enzymes, serum albumin, and bil-
lirubin were unremarkable. Serum amylase was 92 U/L and serum
lipase was 31 U/L. Venous ammonia, urine drug screen, thy-
roid function tests, and troponins were unremarkable. Urinalysis
showed moderate amounts of ketones and elevated urobilinogen.
Activated partial thromboplastin time (aPTT) and International
Normalized Ratio (INR) were normal. Cranial computed tomog-
raphy (CCT) was unremarkable. Computed tomography (CT) of
the chest, abdomen, and pelvis showed a 6 mm right hilar node,
inflammatory changes of the pancreas consistent with pancre-
atitis, peripancreatic air, and abscess formation. There was also
a 4 cm× 7 cm× 4 cm well defined soft tissue mass lesion with
central calcification in the left lower quadrant of the abdomen
(Figure 1). CT findings were remarkably improved compared
to CT of the abdomen taken 3 weeks prior. General surgery
consultant recommended intravenous meropenem. Transthoracic
echocardiography (TTE) showed a left ventricular ejection frac-
tion of 60%, moderate to severe aortic stenosis, and infero-lateral
hypokinesis.
Twelve hours following admission to our hospital, she became
unarousable and was transferred to the Medical Intensive Care
Unit (ICU). Neurology consultation was requested. Examination
showed a comatose patient with a normal breathing pattern. She
had symmetric facial grimacing to sternal rubbing. Pupils were
3 mm symmetric and reactive. Oculocephalic reflexes were nor-
mal. She had a flaccid areflexic tetraparesis, No extensor or flexor
posturing were noted.
Magnetic resonance imaging (MRI) of the brain showed mul-
tiple areas of confluent restricted diffusion involving the splenium
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FIGURE 1 | CT of the abdomen shows an abnormal, poorly defined
collection (6.9 cm×4.7 cm) of gas and inflammatory changes in the
region of the head and uncinate process of the pancreas and dorsal
and inferior to the body of the pancreas. A more focal
(2.1 cm×1.9 cm) fluid density along the posterior left aspect is noted.
of the corpus callosum, right medial occipital white matter, right
brachium pontis, bilateral dorsal pons, and right cerebral pedun-
cle. These regions were associated with non-enhancing hyperin-
tense T2 and fluid attenuated inversion recovery (FLAIR) sequence
without mass effect (Figure 2).
A lumbar puncture (LP) showed an opening pressure of 19 cm
of CSF. There were 176 RBC, 280 WBC (74% segmented, 2% lym-
phocytes, 10% monocytes), glucose content of 49 mg/dL (30% of
serum glucose), and a protein content of 106 mg/dL. Smears, bac-
terial, viral, and fungal cultures, polymerase chain reaction (PCR)
for Herpes Simplex Virus (HSV) type 1 and 2, flow cytometry, and
cytology were negative.
The patient received intravenous Vancomycin 1 gram every
12 h, cefepime 2 g every 12 h, ampicillin 2 g every 4 h, metronida-
zole 500 mg every 6 h,and acyclovir 10 mg/kg every 12 h. Thirty-six
hours after admission the patient exhibited anisocoria; the right
pupil was 4 mm, sluggish and reactive; the left pupil was 2 mm and
reactive. After elective intubation for airway protection, a repeat
CCT was unchanged.
Repeat LP showed 106 RBC, 3 WBC (4% segmented, 86%
lymphocytic, 10% macrophages), glucose content of 68 (45% of
serum),and a protein content of 180. Smears, cultures,flow cytom-
etry, and cytology again were negative. PCR for Epstein Bar virus
(EBV), JC virus, cytomegalovirus (CMV), and cryptococal anti-
gen were negative. Oligoclonal bands and myelin basic protein
were negative.
Serial blood cultures failed to grow any bacteria. Serum human
immunodeficiency virus (HIV) antibodies and HIV PCR analy-
sis were negative. Serum paraneoplastic antibody panel (anti Hu,
Ma1, Ma2, Yo, Ri, Car, Lems, CV2, Zix4, VGKC, Amphiphysin,
G-ACHR), antiphospholipid antibody panel (beta 2 glycoprotein
IgG, IgM, cardiolipin IgG, IgM), thyroid panel including thyroid
stimulating hormone (TSH), free T4, T3, and thyroperoxidase
(TPI) antibodies were all unremarkable.
The patient was transferred to the Neuroscience ICU (NICU).
All antimicrobials were discontinued after 7 days of treatment.
Repeat CT of the abdomen showed improvement of the pancreatic
and peripancreatic abnormalities. Repeat MRI of the brain showed
increased size, on diffusion weighted images, and T2/FLAIR, of
the lesions located in the splenium, posterior white matter, mid-
brain, pons, and cerebellum. These lesions had faint enhancement
following gadolinium administration (Figure 3). MRI of the cervi-
cal spine showed multiple non-contiguous spinal cord expansive
lesions from the cervico-medullary junction to the level of the
sixth cervical vertebra (Figure 4).
Electroencephalography (EEG) showed moderate to severe dif-
fuse background slowing consistent with a moderate to severe
encephalopathy with a possible focal epileptiform activity arising
from the right frontal region. The patient received 1500 mg of
IV levetiracetam followed by 750 mg every 12 h with resolution
of the ictal electrographic phenomenon. Somatosensory evoked
potentials (SSEPs) of the upper and lower extremities were unin-
terpretable due to technical difficulties. Visual evoked potentials
(VEP) showed integrity of the visual pathways.
A right burr hole stereotactic brain biopsy of the splenium
and right occipital lobe showed reactive gliosis and numerous
macrophages. Specific stains for differentiation CD20 (B-cell) and
CD3 (T-cell) showed no prominent lymphocytic infiltrates. Luxol
Fast Blue and Bielschowsky stains showed evidence of demyelina-
tion, with relative preservation of axons. Differential diagnosis at
this point included pontine and extrapontine myelinolysis (EPM).
Despite the scant presence of perivascular lymphocytic inflam-
matory infiltrates, a diagnosis of possible acute disseminated
encephalomyelitis (ADEM) was also entertained.
The patient received1500 mg of IV methylprednisolone daily
for 5 days followed by plasmapheresis for a total of five plasma
exchanges. However, she had no clinical improvement. The patient
remained hospitalized in critical condition for 3 weeks. Repeat
brain and cervical spine MRIs showed no improvement. Hospital
course was complicated by ventilator associated pneumonia and
hypotension requiring vasopressors. Based on advanced directives,
the family decided to discontinue vital support 5 weeks after initial
admission to our hospital. She suffered a respiratory arrest 4 days
after extubation resulting in her death.
AUTOPSY FINDINGS
Macroscopic analysis showed thin translucent leptomeninges
without subarachnoid hemorrhage. There were multiple distinct
white matter lesions including the right occipital lobe, splenium,
and right middle cerebellar peduncle extending into the central
pons. These multiple white matter areas contained numerous
macrophages with focal cavitation containing scattered perivas-
cular and parenchymal T cells (CD3) and B-cells (CD20). The
neurofilament stains revealed preservation of the axons at the
periphery of the lesions, but there was axonal loss in the middle of
the cavitary portions of some of the lesions. Luxol Fast Blue myelin
stains showed areas of demyelination including portions of the
medullary medial lemniscus. Also noted were hyalinized barrel-
shaped vessels in the parietal and occipital cerebral cortical white
matter as well as in the basal ganglia and amygdale consistent with
mild arteriolar sclerosis. Focal gliosis and microglial proliferation
in the thalamus was noted. A simian virus antibody 40 (SV40)
stain for progressive multifocal leukoencephalopathy (polyoma
virus) was negative. In summary, there were multiple cavitated
pontine and extrapontine myelinolytic type lesions with extensive
macrophages, focal cavitation, and scant inflammatory infiltrates
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FIGURE 2 | DW-MRI of the brain shows multiple areas of confluent
restricted diffusion affecting the splenium of the corpus callosum, right
medial occipital white matter, right brachium pontis, bilateral dorsal
pons, and right cerebral peduncle (A). These areas are hyperintense on
Fluid Attenuated Inversion Recovery (FLAIR) sequence. There is no evidence
of mass effect (B).
FIGURE 3 |T1W-MRI with contrast shows lesions located in the
splenium, pons, and cerebellum with minimal contrast enhancement.
in the setting of peripheral pancreatic autolytic changes and peri-
pancreatic fat necrosis and chronic inflammation consistent with
pancreatic encephalopathy (Figures 5 and 6).
DISCUSSION
The osmotic myelinolytic syndromes combine signs and symp-
toms of central nervous system (CNS) myelinolysis. These disor-
ders either affect the pons resulting in central pontine myelinolysis
(CPM), or other CNS resulting in EPM.
Typical symptoms of CPM are biphasic (Adams et al., 1959).
Initially, presenting with encephalopathy or seizures due to
FIGURE 4 |T2W-MRI of the cervical spine shows multiple
non-contiguous expansive lesions from the cervico-medullary junction
to the level of the sixth cervical vertebra (A). T1W-MRI with contrast
demonstrates patchy enhancement (B).
hyponatremia. As normonatremia is established, patients recover
to subsequently deteriorate days later with a flaccid and then spas-
tic quadriparesis, dysphagia, and dysarthria. If the myelinolytic
process extends to the tegmentum, pupillary, and oculomotor
abnormalities are noted.
Extrapontine myelinolysis may affect multiple areas within the
CNS (Table 1). CPM and EPM may occur in isolation or combined
(Gotch and Calmant, 1987) as in our patient. The coexistence of
CPM and EPM may account for a protean clinical picture, often
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preceded by a variety of psychiatric manifestations. The under-
lying pathology of these lesions is characterized by degeneration
and loss of oligodendrocytes with preservation of axons. Lesions
are sharply demarcated. During the active phase of the disease,
they contain sheets of lipid-laden macrophages and large num-
ber of reactive astrocytes. Infiltration by lymphocytes is sparse or
absent (Love, 2006). A variety of potential etiologies have been
identified (Table 2; Tomlinson et al., 1976; Martin, 2004). Patients
with osmotic myelinolysis also have a high prevalence of concomi-
tant hypokalemia (Lohr, 1994). Myelinolysis is best appreciated on
MRI, presenting with non-enhancing hyperintense lesions on T2
and hypointense lesions on T1.
Pancreatic encephalopathy (Rothermich and Von Haam, 1941),
refers to a variety of neuropsychiatric symptoms complicating
acute pancreatitis (Jacewicz and Marino, 2007). Encephalopathy
has been reported in 9–35% of subjects suffering acute pancreatitis
without history of alcoholism (de Falco et al., 1980). Neurologi-
cal manifestations related to acute pancreatitis are multifactorial
FIGURE 5 | H and E stains [(A,B) Low Power; (C) High Power] Multiple
white matter areas containing myelin loss and numerous
macrophages with focal cavitation. Adjacent to areas of myelin loss
there is relative preservation of neurons [(D) High Power].
and may result from hypocalcemia, hypomagnesemia, low thi-
amine levels, or osmotic myelinolysis. Symptoms due to osmotic
myelinolysis include but are not limited to fluctuating mental
status, disorientation, confusion, dysarthria, hallucinations, delir-
ium, akinetic mutism, seizures, and coma (Sharf and Bental,
1971). Symptoms usually present 2–5 days after onset (Chan et al.,
2003), although new neurological symptoms have been reported
more than 1 month after onset of pancreatitis (Ding et al., 2004).
CNS pathological changes include patchy myelin pallor (Vogel,
1951), CPM, EPM (Sherins and Verity, 1968), acute hemorrhagic
leukoencephalitis (Chan et al., 2003), and fat embolism (Bhalla
et al., 2003). Vogel first described scattered foci of intense
demyelinization in cases of pancreatic encephalopathy. He was able
Table 1 | CNS lesions on EPM.
Cerebellum
Lateral geniculate body
External capsule
Extreme capsule
Hippocampus
Putamen
Subcortical areas
Thalamus
Caudate nucleus
Claustrum
Internal capsule
Midbrain
Internal medullary lamellae
Mamillary bodies
Medulla oblongata
Table 2 | Disorders associated with myelinolysis.
Alcoholism
Malnutrition
Prolonged diuretic use
Psychogenic polydipsia
Burns
Post liver transplant
Post pituitary surgery
Post urological/gynecological surgery (s/p glycine infusion)
Pancreatitis
FIGURE 6 | Luxol Fast Blue stains [(A,B) Low power] shows areas with loss of myelin and increased macrophages. The neurofilament stain [(C), Low
power] with preservation of the axons primarily at the periphery of the lesions.
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to demonstrate similar pathological effect in animals by injecting
lipase into the CNS (Vogel, 1951). Other putative physiopathologic
explanations have been postulated including pancreatin activa-
tion, cytokines such as tumor necrosis factor alpha (TNF-α),
Interleukin 1(IL 1). These pro-inflammatory markers and pan-
creatic enzymes were accounted to increase blood brain barrier
permeability, causing vasogenic edema, myelinolysis, inflamma-
tory activation, electrolytic disturbances, and hyperosmolarity due
to osmotic diuresis (Zhang, 2007). Animal models of acute pan-
creatitis have subsequently proven the effect of the mentioned
markers (Farkas et al., 1998). Differential diagnosis of altered
mental status among patients with pancreatitis is extensive. Pan-
creatic encephalopathy should only be considered after more likely
possibilities including ischemia, uremia, hypoxemia, electrolyte
abnormalities, thiamine deficiency, have been excluded (Jacewicz
and Marino, 2007). CSF analysis on patients with pancreatic
encephalopathy show high protein content, mild lymphocytosis,
and lipase (Vogel, 1950; Estrada et al., 1979; Sjaastad et al., 1979).
There is no known treatment for the osmotic demyelinat-
ing syndrome regardless of etiology. In cases of pancreatic
encephalopathy, specific anti-enzymes, such as aprotinin
(Trasylol®), have been proposed. This is a low molecular weight
polypeptide produced by the parotid glands and lung tissues.
Aprotinin inhibits the action of trypsin, chymotrypsin, kallikrein,
fibrinolysin,and other proteolytic enzymes (Sharf and Levy,1976).
Other proposed alternatives for the treatment of myelinolysis
include reinduction of hyponatremia (Oya et al., 2001), recombi-
nant human growth hormone (Qian et al., 2001), plasmapheresis,
IVIG, and corticosteroids (Kumar et al., 2006).
SUMMARY
Our patient had pathology proven pancreatic encephalopathy
affecting large areas of the white matter throughout brain, brain-
stem, and spinal cord. The cystic cavitating components of our
patient’s lesions most likely could be explained by direct prote-
olytic effect of pancreatic enzymes, including lipase. To our knowl-
edge, there is only one other report of a patient presenting with
osmotic myelinolysis affecting the spinal cord, but without accom-
panying and supporting autopsy pathology findings (Pneumatikos
et al., 1998).
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